https://doi.org/10.4081/jbr.2025.12987
0
0
0
0
Smart Citations0
0
0
0
Citing PublicationsSupportingMentioningContrasting
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
The role of miRNA-4516 in regulating Bruton's tyrosine kinase expression and colorectal cancer progression in a sample of Iraqi population
Considering the second-highest global death rate, Colorectal Cancer (CRC) is the second most prevalent form of cancer in women and the third most frequent cancer type in men. Bruton's Tyrosine Kinase (BTK) is a soluble tyrosine kinase that plays essential functions in B cell maturation, development, and signaling. It has been discovered that BTK controls cell migration, survival, and proliferation in a variety of B-cell malignancies. The category of short non-coding RNAs known as microRNAs (miRNAs) is involved in several biological processes, including the development and propagation of tumors. The current study was designed to measure the gene expression level of the BTK gene and miR-4516 in Iraqi CRC patients; 100 blood samples were collected, RNA extracted, converted into cDNA, and then expression levels were measured using quantitative real-time PCR. The results showed that there were statistically significant differences among the patients and the control with a P-value (=0.005) in the expression level of miR-4516, while the results of the BTK gene showed that there were no significant differences between the CRC patients and control groups of the current study. This study reveals that non-detectable levels of BTK secretion may be attributed to miR-4516 mediated suppression or due to BTK possessing a dual role in tumorigenesis, capable of either promoting tumor growth or inducing programmed cell death. Elevated levels of miR-4516 are believed to contribute to the development of CRC by regulating the expression of specific genes, including BTK, making it a promising target for both monitoring and therapeutic of the disease.
Armaghany T, Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointest Cancer Res 2012;5:19–27.
Paschke S, Jafarov S, Staib L, et al. Are colon and rectal cancer two different tumor entities? A proposal to abandon the term colorectal cancer. Int J Mol Sci 2018;19:2577.
DOI: https://doi.org/10.3390/ijms19092577
Basile D, Gerratana L, Buonadonna A, et al. Role of Bruton’s Tyrosine Kinase in stage III colorectal cancer. Cancers (Basel) 2019;11:880.
DOI: https://doi.org/10.3390/cancers11060880
Annual Report Iraqi Cancer Registry [Internet]. 2020. Available from: https://moh.gov.iq/upload/2991322580.pdf
Mouhssine S, Maher N, Matti BF, et al. Targeting BTK in B cell malignancies: From mode of action to resistance mechanisms. Int J Mol Sci 2024;25:3234
DOI: https://doi.org/10.3390/ijms25063234
Rada M, Barlev N, Macip S. BTK: a two-faced effector in cancer and tumour suppression. Cell Death Dis 2018;9:1064.
DOI: https://doi.org/10.1038/s41419-018-1122-8
Wang Y, Zhang LL, Champlin RE, Wang ML. Targeting Bruton’s tyrosine kinase with ibrutinib in B-cell malignancies. Clin Pharmacol Ther 2015;97:455–68.
DOI: https://doi.org/10.1002/cpt.85
Qin Y, Lu F, Lyu K, et al. Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity. Front Immunol 2022;13:881427.
DOI: https://doi.org/10.3389/fimmu.2022.881427
Yang T, Hao L, Chen J, et al. BTK is a prognostic biomarker for multiple human tumors. 2022. Available from: https://www.researchgate.net/publication/365883496_BTK_is_a_Prognostic_Biomarker_for_Multiple_Human_Tumors
DOI: https://doi.org/10.21203/rs.3.rs-2278617/v1
Weber ANR, Bittner Z, Liu X, et al. Bruton’s Tyrosine Kinase: An emerging key player in innate immunity. Front Immunol 2017;8:1454.
DOI: https://doi.org/10.3389/fimmu.2017.01454
Bi K-W, Wei X-G, Qin X-X, Li B. BTK has potential to be a prognostic factor for lung adenocarcinoma and an indicator for tumor microenvironment remodeling: A study based on TCGA data mining. Front Oncol 2020;10:424.
DOI: https://doi.org/10.3389/fonc.2020.00424
NCBI. BTK Bruton tyrosine kinase [ Homo sapiens (human) ] [Internet]. Available from: https://www.ncbi.nlm.nih.gov/gene/695
Gene cards [Internet]. Available from: https://www.genecards.org/cgi-bin/carddisp.pl?gene=BTK
Ponader S, Burger JA. Bruton’s tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies. J Clin Oncol Off J Am Soc Clin Oncol 2014;32:1830–9.
DOI: https://doi.org/10.1200/JCO.2013.53.1046
Grassilli E, Pisano F, Cialdella A, et al. A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation. Oncogene 2016;35:4368–78.
DOI: https://doi.org/10.1038/onc.2015.504
Omran MM, Fouda MS, Mekkawy SA, et al. Molecular biomarkers and signaling pathways of cancer stem cells in colorectal cancer. Technol Cancer Res Treat 2024;23:15330338241254060.
DOI: https://doi.org/10.1177/15330338241254061
Giordano F, Vaira V, Cortinovis D, et al. p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma. J Exp Clin Cancer Res 2019;38:260.
DOI: https://doi.org/10.1186/s13046-019-1199-7
AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov 2017;7:818–31.
The National Center for Biotechnology Information (NCBI) [Internet]. Available from: https://www.ncbi.nlm.nih.gov/
Mohamed AJ, Yu L, Bäckesjö C-M, et al. Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain. Immunol Rev 2009;228:58–73.
DOI: https://doi.org/10.1111/j.1600-065X.2008.00741.x
Uckun FM. Bruton’s tyrosine kinase (BTK) as a dual-function regulator of apoptosis. Biochem Pharmacol 1998;56:683–91.
DOI: https://doi.org/10.1016/S0006-2952(98)00122-1
Wang M, Yu F, Wu W, et al. Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity. Int J Biol Sci 2017;13:1497–506.
DOI: https://doi.org/10.7150/ijbs.22531
Abdulhassn ML, Al-Khafaji HMAH, Mohammed MQ. Assessment of the TGF-β gene and its target miR-1908-5p gene expression and its role in the treatment of beta-thalassemia in Iraqi patients. Iraqi J Hematol 2024; 10.4103/ijh.ijh_82_24.
DOI: https://doi.org/10.4103/ijh.ijh_82_24
Khan AQ, Ahmed EI, Elareer NR, et al. Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies. Cells 2019;8:840.
DOI: https://doi.org/10.3390/cells8080840
Kudelova E, Holubekova V, Grendar M, et al. Circulating miRNA expression over the course of colorectal cancer treatment. Oncol Lett 2022;23:18.
DOI: https://doi.org/10.3892/ol.2021.13136
The National Center for Biotechnology Information (NCBI). 2024. Available from: https://www.ncbi.nlm.nih.gov/gene/100616258
Liu J, Chen D, Liu H, et al. A microRNA-4516 inhibitor sensitizes chemo-resistant gastric cancer cells to chemotherapy by upregulating ING4. RSC Adv 2018;8:37795–803.
DOI: https://doi.org/10.1039/C8RA06419A
Fuhua W, Chunyan W, Xiangyun G, et al. Expression of serum miRNA-4516 and its clinical significance and predicted target genes in hepatocellular carcinoma. Chin J Integr Tradit West Med Dig 2021;29:86–9.
Chen S, Xu M, Zhao J, et al. MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1. Int J Biol Sci 2020;16:2159–69.
DOI: https://doi.org/10.7150/ijbs.45933
Jin X-H, Lu S, Wang A-F. Expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer. BMC Cancer 2020;20:241.
DOI: https://doi.org/10.1186/s12885-020-06715-6
Yue C, Niu M, Shan QQ, et al. High expression of Bruton’s tyrosine kinase (BTK) is required for EGFR-induced NF-κB activation and predicts poor prognosis in human glioma. J Exp Clin Cancer Res 2017;36:132.
DOI: https://doi.org/10.1186/s13046-017-0600-7
Donati S, Ciuffi S, Brandi ML. Human circulating miRNAsreal-time qRT-PCR-based analysis: An overview of endogenous reference genes used for data normalization. Int J Mol Sci 2019;20:4353.
DOI: https://doi.org/10.3390/ijms20184353
Metzler JM, Burla L, Fink D, Imesch P. Ibrutinib in gynecological malignancies and breast cancer: A systematic review. Int J Mol Sci 2020;21:4154.
DOI: https://doi.org/10.3390/ijms21114154
Patel RK, West JD, Jiang Y, et al. Robust partitioning of microRNA targets from downstream regulatory changes. Nucleic Acids Res 2020;48:9724–46.
DOI: https://doi.org/10.1093/nar/gkaa687
Ghareeb ZA, Al-Khafaji HMA-H, Al-Saedi MKA. Low-density lipoprotein receptor-related protein-1 and mir-205 expression for cardiovascular disease in familial hypercholesterolemia and non-familial hypercholesterolemia in Iraqi population. Iran J Ichthyol 2021;8:246–54.
DOI: https://doi.org/10.53293/jasn.2021.3691.1036
Dai B, Chen A, Corkum C, et al. Hepatitis C virus upregulates B-cell receptor signaling: A novel mechanism for HCV-associated B-cell lymphoproliferative disorders. Oncogene 2016;35:2979–90.
DOI: https://doi.org/10.1038/onc.2015.364
Faeqali Jan M, Muneer Al-Khafaji H, Hasan Al-Saadi B, Aneed Al-Saedi MK. Assessment of interleukin-8 in bronchial asthma in Iraq. Arch Razi Inst 2021;76:913–23.
Umair Z, Baek M-O, Song J, et al. MicroRNA-4516 in urinary exosomes as a biomarker of premature ovarian insufficiency. Cells 2022;11:2797.
DOI: https://doi.org/10.3390/cells11182797
Chen Y, Guo Y, Li Y, et al. miR‑300 regulates tumor proliferation and metastasis by targeting lymphoid enhancer‑binding factor 1 in hepatocellular carcinoma. Int J Oncol 2019;54:1282–94.
DOI: https://doi.org/10.3892/ijo.2019.4715
Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101–8.
DOI: https://doi.org/10.1038/nprot.2008.73
Riedel G, Rüdrich U, Fekete-Drimusz N, et al. An extended ΔCT-method facilitating normalisation with multiple reference genes suited for quantitative RT-PCR analyses of human hepatocyte-like cells. PLoS One 2014;9:e93031.
DOI: https://doi.org/10.1371/journal.pone.0093031
SPSS. Statistical Package for the Social Sciences. 2019. p. Version 26.
Iorio M V, Croce CM. Causes and consequences of microRNA dysregulation. Cancer J 2012;18:215–22.
DOI: https://doi.org/10.1097/PPO.0b013e318250c001
Lulli M, Napoli C, Landini I, et al. Role of non-coding RNAs in colorectal cancer: Focus on Long Non-Coding RNAs. Int J Mol Sci 2022;23:13431.
DOI: https://doi.org/10.3390/ijms232113431
Ždralević M, Radović A, Raonić J, et al. Advances in microRNAs as emerging biomarkers for colorectal cancer early detection and diagnosis. Int J Mol Sci 2024;25:11060
DOI: https://doi.org/10.3390/ijms252011060
Henke E, Nandigama R, Ergün S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol Biosci 2019;6:160.
DOI: https://doi.org/10.3389/fmolb.2019.00160
Eble JA, Niland S. The extracellular matrix in tumor progression and metastasis. Clin Exp Metastasis 2019;36:171–98.
DOI: https://doi.org/10.1007/s10585-019-09966-1
Messex JK, Liou G-Y. Targeting BTK signaling in the microenvironment of solid tumors as a feasible cancer therapy option. Cancers 2021;13:2198.
DOI: https://doi.org/10.3390/cancers13092198
Cerrito MG, Grassilli E. Identifying novel actionable targets in colon cancer. Biomedicines. 2021;9:579.
DOI: https://doi.org/10.3390/biomedicines9050579
McCay J, Gribben JG. The role of BTK inhibitors on the tumor microenvironment in CLL. Leuk Lymphoma 2022;63:2023–32.
DOI: https://doi.org/10.1080/10428194.2022.2064995
Pal Singh S, Dammeijer F, Hendriks RW. Role of Bruton’s tyrosine kinase in B cells and malignancies. Mol Cancer 2018;17:57.
DOI: https://doi.org/10.1186/s12943-018-0779-z
Slattery ML, Herrick JS, Mullany LE, et al. The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer. Genes Chromosomes Cancer 2017;56:769–87.
DOI: https://doi.org/10.1002/gcc.22481
Özkan G, Ulusoy Ş, Geyik E, Erdem Y. Down-regulation of miRNA 145 and up-regulation of miRNA 4516 may be associated with primary hypertension. J Clin Hypertens (Greenwich) 2019;21:1724–31.
DOI: https://doi.org/10.1111/jch.13704
Good L, Benner B, Carson WE. Bruton’s tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment. Cancer Immunol Immunother 2021;70:2439–51.
DOI: https://doi.org/10.1007/s00262-021-02908-5
How to Cite
Hassain, A. S., Al-Khafaji, H. M. A. H., & Mohammed, M. Q. (2025). The role of miRNA-4516 in regulating Bruton’s tyrosine kinase expression and colorectal cancer progression in a sample of Iraqi population. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale. https://doi.org/10.4081/jbr.2025.12987
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.